Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
7.38
+0.29 (4.09%)
At close: Feb 26, 2026, 4:00 PM EST
7.02
-0.36 (-4.89%)
After-hours: Feb 26, 2026, 4:56 PM EST

Climb Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
3521217498278-
Market Cap Growth
231.74%62.54%-23.65%-64.90%--
Enterprise Value
177-97-33-32108-
Last Close Price
7.381.802.703.6710.46-
PB Ratio
2.840.570.690.761.66-
P/TBV Ratio
1.990.570.690.761.66-
Debt / Equity Ratio
0.000.000.000.00--
Net Debt / Equity Ratio
-0.99-1.00-0.99-0.96-0.96-0.93
Quick Ratio
17.5630.8338.5721.3523.798.16
Current Ratio
18.3831.4138.9222.0424.588.76
Return on Equity (ROE)
-25.65%-46.26%-29.72%-30.58%-50.16%-96.73%
Return on Assets (ROA)
-17.35%-10.30%-10.93%-18.30%-22.54%-31.96%
Return on Capital Employed (ROCE)
-31.70%-12.70%-19.90%-35.00%-21.30%-53.20%
Earnings Yield
-14.40%-61.07%-47.17%-46.40%-17.09%-
Buyback Yield / Dilution
-76.96%-78.47%-2.57%-114.60%-460.40%-31.72%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q